Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ARCTCompany Name
ARCTURUS THERAPEUTICS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARCTURUS THERAPEUTICS HOLDINGS INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ARCT - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 309.29M | $ -64.94M | 0 |
| 3/31/2025 | $ 314.33M | $ -89.33M | 0 |
| 12/31/2024 | $ 433.1M | $ -59.75M | 0 |
| 9/30/2024 | $ 507.62M | $ -60.09M | 0 |
| 6/30/2024 | $ 535.17M | $ -68.73M | 0 |
| 3/31/2024 | $ 732.81M | $ 12.21M | 59.99 |
| 12/31/2023 | $ 978.91M | $ -18.1M | 0 |
| 9/30/2023 | $ 518.43M | $ 142.79M | 3.63 |
| 6/30/2023 | $ 847.16M | $ 132.79M | 6.38 |
| 3/31/2023 | $ 769M | $ 45.16M | 17.03 |
Key Performance Insights, Last 5 Years
- ARCTURUS THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, ARCTURUS THERAPEUTICS HOLDINGS INC's average P/OCF has been 20.75.
- The median P/OCF for ARCTURUS THERAPEUTICS HOLDINGS INC during this period was 16.74
- ARCTURUS THERAPEUTICS HOLDINGS INC reached its highest P/OCF over the past 5 years at 59.99.
- The lowest P/OCF recorded by ARCTURUS THERAPEUTICS HOLDINGS INC in the same timeframe 3.63
ARCTURUS THERAPEUTICS HOLDINGS INC's P/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/OCF Benchmarks
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for ARCTURUS THERAPEUTICS HOLDINGS INC is calculated as follows: Market Cap [ $ 847.71M ] / CF - Operations [ $ -43.77M ]
(=) P/OCF [ 0 ] ARCT - Price to Operating Cash Flow, Last 5 years
3.63
Minimum
Sep 30, 2023
59.99
Maximum
Mar 31, 2024
20.75
Average
16.74
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.81.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.03 |
| average | 13.1 |
| median | 10.77 |
| std | 8.81 |